Article
Production of rAAV by plasmid transfection induces antiviral and inflammatory responses in suspension HEK293 cells
16 Jan 2023
Abstract excerpt
Recombinant adeno-associated virus (rAAV) is a clinically proven viral vector for delivery of therapeutic genes to treat rare diseases. Improving rAAV manufacturing productivity and vector quality is necessary to meet clinical and commercial demand. These goals will require an improved understanding of the cellular response to rAAV production, which is poorly defined. We interrogated the kinetic transcriptional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
